Regulation of matrix metalloproteinases is at the heart of myocardial remodeling.
作者信息
Levick Scott P, Brower Gregory L
出版信息
Am J Physiol Heart Circ Physiol. 2008 Oct;295(4):H1375-6. doi: 10.1152/ajpheart.907.2008. Epub 2008 Aug 29.
Abstract
摘要
相似文献
1
Regulation of matrix metalloproteinases is at the heart of myocardial remodeling.
Am J Physiol Heart Circ Physiol. 2008 Oct;295(4):H1375-6. doi: 10.1152/ajpheart.907.2008. Epub 2008 Aug 29.
2
Cardiac-restricted overexpression of extracellular matrix metalloproteinase inducer causes myocardial remodeling and dysfunction in aging mice.
Am J Physiol Heart Circ Physiol. 2008 Oct;295(4):H1394-402. doi: 10.1152/ajpheart.00346.2008. Epub 2008 Aug 8.
3
TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation.
Circ Res. 2010 Mar 5;106(4):796-808. doi: 10.1161/CIRCRESAHA.109.209189. Epub 2010 Jan 7.
4
Biomarkers of Myocardial Fibrosis: Revealing the Natural History of Fibrogenesis in Fabry Disease Cardiomyopathy.
J Am Heart Assoc. 2018 Mar 13;7(6):e007124. doi: 10.1161/JAHA.117.007124.
5
Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
Circulation. 2011 Nov 8;124(19):2094-105. doi: 10.1161/CIRCULATIONAHA.111.030338. Epub 2011 Oct 10.
6
Myocardial lysyl oxidase regulation of cardiac remodeling in a murine model of diet-induced metabolic syndrome.
Am J Physiol Heart Circ Physiol. 2009 Sep;297(3):H976-82. doi: 10.1152/ajpheart.00398.2009. Epub 2009 Jul 10.
7
Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice.
Circ Heart Fail. 2015 Jul;8(4):788-98. doi: 10.1161/CIRCHEARTFAILURE.114.001963. Epub 2015 May 18.
8
Increased C-reactive protein expression exacerbates left ventricular dysfunction and remodeling after myocardial infarction.
Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1795-804. doi: 10.1152/ajpheart.00001.2010. Epub 2010 Sep 17.
9
Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction.
Circ Res. 2009 Mar 13;104(5):699-706. doi: 10.1161/CIRCRESAHA.108.189746. Epub 2009 Jan 24.
10
Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction.
Am J Physiol Heart Circ Physiol. 2007 Apr;292(4):H1847-60. doi: 10.1152/ajpheart.00434.2006. Epub 2006 Dec 8.
引用本文的文献
1
Autophagy inhibition of hsa-miR-19a-3p/19b-3p by targeting TGF-β R II during TGF-β1-induced fibrogenesis in human cardiac fibroblasts.
Sci Rep. 2016 Apr 21;6:24747. doi: 10.1038/srep24747.
2
Role of caveolin-1 in atrial fibrillation as an anti-fibrotic signaling molecule in human atrial fibroblasts.
PLoS One. 2014 Jan 14;9(1):e85144. doi: 10.1371/journal.pone.0085144. eCollection 2014.
3
Collagen XIV is important for growth and structural integrity of the myocardium.
J Mol Cell Cardiol. 2012 Nov;53(5):626-38. doi: 10.1016/j.yjmcc.2012.08.002. Epub 2012 Aug 11.
4
Cyclophilin-CD147 interactions: a new target for anti-inflammatory therapeutics.
Clin Exp Immunol. 2010 Jun;160(3):305-17. doi: 10.1111/j.1365-2249.2010.04115.x. Epub 2010 Mar 16.
本文引用的文献
1
Cardiac-restricted overexpression of extracellular matrix metalloproteinase inducer causes myocardial remodeling and dysfunction in aging mice.
Am J Physiol Heart Circ Physiol. 2008 Oct;295(4):H1394-402. doi: 10.1152/ajpheart.00346.2008. Epub 2008 Aug 8.
2
Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.
Physiol Rev. 2007 Oct;87(4):1285-342. doi: 10.1152/physrev.00012.2007.
3
EMMPRIN mediates beta-adrenergic receptor-stimulated matrix metalloproteinase activity in cardiac myocytes.
J Mol Cell Cardiol. 2008 Jan;44(1):210-7. doi: 10.1016/j.yjmcc.2007.07.054. Epub 2007 Jul 31.
4
Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction.
Circulation. 2006 Feb 14;113(6):834-41. doi: 10.1161/CIRCULATIONAHA.105.568162. Epub 2006 Feb 6.
5
Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation.
Cardiovasc Res. 2006 Feb 15;69(3):666-76. doi: 10.1016/j.cardiores.2005.10.004. Epub 2006 Jan 19.
6
Upstream regulation of matrix metalloproteinase by EMMPRIN; extracellular matrix metalloproteinase inducer in advanced atherosclerotic plaque.
Atherosclerosis. 2005 May;180(1):37-44. doi: 10.1016/j.atherosclerosis.2004.11.021. Epub 2005 Jan 19.
7
EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair.
Biochimie. 2005 Mar-Apr;87(3-4):361-8. doi: 10.1016/j.biochi.2004.09.023.
8
Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression.
Thromb Haemost. 2005 Feb;93(2):199-204. doi: 10.1160/TH04-08-0536.
9
The dynamic interaction between matrix metalloproteinase activity and adverse myocardial remodeling.
Heart Fail Rev. 2004 Jan;9(1):33-42. doi: 10.1023/B:HREV.0000011392.03037.7e.
10
Matrix metalloproteinase disruption of the extracellular matrix and cardiac dysfunction.
Trends Cardiovasc Med. 2002 Apr;12(3):97-101. doi: 10.1016/s1050-1738(01)00160-8.
Zotero 插件